These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1830503

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Rapid prenatal diagnosis of Down's syndrome in the first trimester of pregnancy by fluorescence in situ hybridization].
    Xiang Y, Sun N, Wang F.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):646-8. PubMed ID: 9639761
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Measurement of choriogonadotropin free beta-subunit: an alternative to choriogonadotropin in screening for fetal Down's syndrome?
    Knight GJ, Cole LA.
    Clin Chem; 1991 Jun; 37(6):779-82. PubMed ID: 1828723
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biochemical screening for Down's syndrome.
    Connor M.
    BMJ; 1993 Jun 26; 306(6894):1705-6. PubMed ID: 8343623
    [No Abstract] [Full Text] [Related]

  • 29. Serum screening for Down's syndrome. Counselling should emphasise possible outcomes of screening.
    Allaby M.
    BMJ; 1994 Nov 19; 309(6965):1373. PubMed ID: 7866103
    [No Abstract] [Full Text] [Related]

  • 30. Fluorescent in-situ hybridisation and Down's syndrome.
    Seres-Santamaria A, Catala V, Cuatrecasas E, Villanueva R.
    Lancet; 1993 Jun 12; 341(8859):1544. PubMed ID: 8099427
    [No Abstract] [Full Text] [Related]

  • 31. Early and rapid prenatal exclusion of Down's syndrome.
    Bryndorf T, Sundberg K, Christensen B, Philip J, Yokobata K, Gaiser C.
    Lancet; 1994 Mar 26; 343(8900):802. PubMed ID: 7907766
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF.
    Med J Aust; 1991 Sep 02; 155(5):349. PubMed ID: 1832734
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB, Nikolenko MI, Khlevnaia LA, Fedotova OO, Solov'eva VD, Malova SA.
    Tsitol Genet; 1998 Sep 02; 32(1):66-71. PubMed ID: 9695254
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Screening for Down's syndrome. Costings are crucial to model.
    Whittle M.
    BMJ; 2002 Jan 12; 324(7329):111. PubMed ID: 11808521
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.